Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
671,331
-
Share change
-
-121,367
-
Total reported value
-
$10,202,395
-
Price per share
-
$15.20
-
Number of holders
-
20
-
Value change
-
-$1,650,874
-
Number of buys
-
9
-
Number of sells
-
10
Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q4 2022
As of 31 Dec 2022,
Greenwich LifeSciences, Inc. - COM (GLSI) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
671,331 shares.
The largest 10 holders included
VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, BlackRock Inc., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, GSA CAPITAL PARTNERS LLP, and 683 Capital Management, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.